We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Basilea Pharmaceutica Ag | LSE:0QNA | London | Ordinary Share | CH0011432447 | BASILEA PHARMACEUTICA ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 46.20 | 45.05 | 47.35 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 9,994 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 150.28M | 10.45M | 0.8708 | 60.67 | 554.49M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 05/2/2025 | 06:15 | UKREG | Strong launch for Cresemba in Japan triggers first sales milestone payment.. |
| 05/2/2025 | 06:15 | UKREG | Starker Verkaufsstart von Cresemba in Japan löst erste.. |
| 28/1/2025 | 06:15 | UKREG | Starkes Verkaufswachstum von Cresemba und Zevtera löst weitere.. |
| 28/1/2025 | 06:15 | UKREG | Strong sales growth for Cresemba and Zevtera trigger further milestone.. |
| 08/1/2025 | 06:15 | UKREG | Basilea informiert über Stand seines Portfolios und gibt Ausblick |
| 08/1/2025 | 06:15 | UKREG | Basilea provides portfolio update and outlook |
| 23/12/2024 | 06:15 | UKREG | Basilea erhält zusätzliche CARB-X-Förderung für die Entwicklung eines.. |
| 23/12/2024 | 06:15 | UKREG | Basilea is awarded additional CARB-X funding to develop new drug candidate.. |
| 16/12/2024 | 06:15 | UKREG | Basilea gibt Vereinbarung mit Innoviva Specialty Therapeutics zur.. |
| 16/12/2024 | 06:15 | UKREG | Basilea announces agreement with Innoviva Specialty Therapeutics for the.. |
1 Year Basilea Pharmaceutica Chart |
Intraday Basilea Pharmaceutica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
